Static Chart Lytix Biopharma

Equities

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-05-24 am EDT			5-day change	1st Jan Change
6 ^NOK	+13.21%		+7.14%	+23.46%

Apr. 25	Lytix Biopharma Announces Approval of the Phase II Study in Early-Stage Skin Cancer Representing A Significant Commercial Opportunity	CI
Apr. 10	Lytix Biopharma to Raise Up to NOK55 Million via Share Offering	MT

Duration

Period